Citation: Ds. Knopman, Advances in methodology and current prospects for primary drug therapies for Alzheimer's disease, METH MOL M, 32, 2000, pp. 45-61
Citation: Sw. Barger, Production and functional assays of recombinant secreted amyloid precursorprotein (APP) (sAPP alpha), METH MOL M, 32, 2000, pp. 63-78
Citation: M. Staufenbiel et Pa. Paganetti, Electrophoretic separation and immunoblotting of A beta(1-40) and A beta(1-42), METH MOL M, 32, 2000, pp. 91-99
Authors:
Brunden, KR
Kocsis-Angle, J
Embury, P
Yates, SL
Citation: Kr. Brunden et al., A beta-induced proinflammatory cytokine release from differentiated human THP-1 monocytes, METH MOL M, 32, 2000, pp. 101-112
Citation: J. Walter et C. Haass, Posttranslational modifications of amyloid precursor protein - Ectodomain phosphorylation and sulfation, METH MOL M, 32, 2000, pp. 149-168
Citation: Cw. Gray et Eh. Karran, Development of neoepitope antibodies against the beta-secretase cleavage site in the amyloid precursor protein, METH MOL M, 32, 2000, pp. 217-228
Citation: M. Citron, beta-secretase - Tissue culture studies of sequence specificity, inhibitors, and candidate enzymes, METH MOL M, 32, 2000, pp. 229-238
Citation: Pa. Paganetti et M. Staufenbiel, Using gamma-secretase inhibitors to distinguish the generation of the A beta peptides terminating at Val-40 and Ala-42, METH MOL M, 32, 2000, pp. 239-248
Citation: Jf. Loring, Designing animal models of Alzheimer's disease with amyloid precursor protein (APP) transgenes, METH MOL M, 32, 2000, pp. 249-270
Citation: Et. Parkin et al., Distribution of presenilins and amyloid precursor protein (APP) in detergent-insoluble membrane domains, METH MOL M, 32, 2000, pp. 345-360